keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GLP-1(28-36)amide acetate 抑制线粒体通透性转变,具有抗氧化、抗糖尿病和心脏保护活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,230 | 现货 | ||
5 mg | ¥ 2,530 | 现货 | ||
10 mg | ¥ 3,770 | 现货 | ||
25 mg | ¥ 5,950 | 现货 | ||
50 mg | ¥ 8,380 | 现货 | ||
100 mg | ¥ 11,200 | 现货 | ||
500 mg | ¥ 22,600 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 5,130 | 现货 |
产品描述 | GLP-1(28-36)amide acetate inhibits mitochondrial permeability transition with antioxidant, anti-diabetic and cardioprotection activities. |
体外活性 | The plasma half-life of GLP-1(28-36)amide acetate is longer in human hepatocytes (24 min) than that in mouse hepatocytes (13 min). GLP-1(28-36)amide acetate (100 nM) on hepatocytes modulates mitochondrial oxidative metabolism including gluconeogenesis in mitochondria of hepatocytes[1]. |
体内活性 | In high-fat diet-fed mice, GLP-1(28-36)amide acetate (18.5 nmol/kg) improved hepatic glucose disposal. In diet-induced obese mice, GLP-1(28-36)amide acetate (18.5 nmol/kg BW/day) diminishes the development of hepatic steatosis. In male C57BL6/J mice, administration of GLP-1(28-36)amide acetate for 20 min to, then isolated hearts underwent 30 min of global ischemia and 40 min of reperfusion, the recovery of left ventricular developed pressure is significantly great. In a β-cell injury diabetic mouse model, GLP-1(28-36)amide acetate (18 nmol/kg; i.p.) shows cytoprotective effect on pancreatic β cells by promoting proliferation and increasing mass[1]. |
别名 | GLP-1(28-36)amide acetate(1225021-13-5 Free base) |
分子量 | 1148.4 |
分子式 | C56H89N15O11 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11.48 mg/mL (10 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 0.8708 mL | 4.3539 mL | 8.7078 mL | 21.7694 mL |
5 mM | 0.1742 mL | 0.8708 mL | 1.7416 mL | 4.3539 mL | |
10 mM | 0.0871 mL | 0.4354 mL | 0.8708 mL | 2.1769 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GLP-1(28-36)amide acetate GPCR/G Protein oxidation-reduction Antioxidant Glucagon Receptor GLP 1(28 36)amide acetate GLP1(2836)amide acetate GLP-1amide acetate(1225021-13-5 Free base) GLP-1(28-36)amide acetate(1225021-13-5 Free base) GLP-1amide Acetate Inhibitor inhibitor inhibit